Plain-English translation of NCT05766098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at the genetic makeup of papillary thyroid cancer by analyzing tumor tissue samples. Researchers want to identify specific genetic mutations that commonly occur in this type of cancer, which can help doctors understand how the cancer might behave and predict how patients might respond to different treatments.
About 80% of papillary thyroid cancers have mutations in certain genes that drive cancer growth. By mapping these genetic patterns in a large group of patients, doctors hope to better predict which patients will have more aggressive cancers and which treatments are most likely to work for each person.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will analyze tumor tissue that was already removed during your surgery or biopsy. They will use a special genetic test called Mass-ARRAY to identify mutations in your cancer cells. Your genetic results will be linked with your medical history and prognosis information so doctors can understand patterns between specific mutations and patient outcomes.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy
Enrollment target
~600 participants
Started
January 2019
Primary completion
October 2027
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marina Muzza, PhD
Istituto Auxologico Italiano-Milan, Italy
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.